Article on - Cytodyn's $100M Mixed Shelf Filing
The best part of the article for me?
Conclusion: A High-Conviction Play
Cytodyn's $100 million mixed shelf filing is more than a financial maneuver; it's a vote of confidence in its pipeline and leadership's ability to navigate the biotech landscape.
Posted Jul 26, 2025, 4:03 PM UTC
5014